Institutional Ownership
Dianthus Therapeutics Inc
CUSIP 252828108COMDNTHQ1 2026
13D / 13G Filings
51
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
234
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
51 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Ra Capital Management, L.P. | 13G/A | 6.0% | 2.61M | SEC |
| 2 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 6.9% | 2.98M | SEC |
| 3 | Nov 25, 2025 | Fairmount Funds Management LLC | 13D/A | 4.9% | — | SEC |
| 4 | Nov 19, 2025 | Avidity Partners Management LP | 13D/A | 4.9% | — | SEC |
| 5 | Nov 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.5% | 3.87M | SEC |
| 6 | Nov 14, 2025 | Octagon Capital Advisors LP | 13G/A | 6.1% | 2.42M | SEC |
| 7 | Nov 14, 2025 | Bcls Fund III Investments, LP | 13G/A | 4.0% | 1.32M | SEC |
| 8 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 9 | Nov 14, 2025 | Vestal Point Capital, LP | 13G/A | 3.0% | 1.18M | SEC |
| 10 | Nov 12, 2025 | Wellington Management Group LLP | 13G | 6.5% | 2.58M | SEC |
41 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Dianthus Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 7.77M | $651.86M |
| 2 | Blackrock, Inc. | 3.18M | $266.50M |
| 3 | Ra Capital Management, L.P. | 2.61M | $219.18M |
| 4 | Wellington Management Group LLP | 2.60M | $217.84M |
| 5 | Fairmount Funds Management LLC | 2.54M | $212.92M |
| 6 | Avidity Partners Management LP | 2.10M | $176.58M |
| 7 | Octagon Capital Advisors LP | 1.95M | $163.36M |
| 8 | Tcg Crossover Management, LLC | 1.68M | $140.70M |
| 9 | Citadel Advisors LLC | 1.61M | $135.15M |
| 10 | State Street Corp | 1.40M | $117.40M |